For recently diagnosed pulmonary arterial hypertension (PAH), adding sotatercept (Winrevair) to standard care lowered the ...

Prescribing the biologic drug sotatercept alongside standard treatment for the most severe form of pulmonary hypertension ...

Sotatercept, an activin-signaling inhibitor, reduces morbidity and mortality among patients with long-standing pulmonary ...

Patients with chronic obstructive pulmonary disease (COPD) face a significant cardiovascular burden both before and after diagnosis. Analyses presented at the European Respiratory Society (ERS) ...

Prescribing the biologic drug sotatercept alongside standard treatment for the most severe form of pulmonary hypertension ...

Angiotensin-converting enzyme (ACE) inhibitor therapy may reduce all-cause mortality in idiopathic pulmonary fibrosis (IPF) but not in COPD.

C hronic Obstructive Pulmonary Disease (COPD) is a progressive lung condition—primarily chronic bronchitis and ...

MSD has announced positive Phase III HYPERION trial results showing Winrevair (sotatercept-csrk) reduced clinical worsening ...

Singing can improve the quality of life of people with lung disease and help reduce their symptoms, according to a ...

To understand the hidden dimensions of COPD among non-smokers, The Week spoke with pulmonologist Dr Shahid Patel, consultant ...

Veterans with COPD and current tobacco use faced a reduced likelihood for tobacco dependence treatment if they lived in a ...